GSK Gets to Appeal Zantac Expert Testimony Ruling in Delaware

GSK Plc got approval from Delaware’s top court Tuesday to quickly appeal a ruling allowing expert testimony at trial over whether the discontinued heartburn medication Zantac causes cancer.

The “unique circumstances presented by this mass tort litigation” raise the case to the Delaware Supreme Court’s strict standards for interlocutory review, Justice N. Christopher Griffiths wrote in an order. The court rarely accepts mid-case appeals.

The Zantac litigation in the Delaware Superior Court is proceeding on two tracks: one to address whether ingesting the drug marketed as Zantac is capable of causing cancer, and the other to identify representative cases ...